In order to determine if mutant KRas can lead to PKD1 expression, we first analyzed a panel of PDA cell lines as well as normal human pancreatic ductal epithelial (HPDE) cells as a control. The gene discussed is PKD1; the disease is Patent ductus arteriosus.